NEW YORK (GenomeWeb News) – Arrayit said today that Sandia National Laboratories will use the company’s nanotechnology platform to develop microarrays for use in anti-bioterror efforts.

Sandia Labs will use Arrayit’s nanoliter technology to develop microarrays, biosensors, and other sensor tools for use in detecting biological and chemical agents that could be part of a terrorism event.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.